scispace - formally typeset
F

Francesco Spigonardo

Researcher at University of Rome Tor Vergata

Publications -  10
Citations -  1300

Francesco Spigonardo is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Simvastatin & Myocardial infarction. The author has an hindex of 9, co-authored 10 publications receiving 1243 citations. Previous affiliations of Francesco Spigonardo include University of Chieti-Pescara.

Papers
More filters
Journal ArticleDOI

Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans

TL;DR: The expression of 5-LO is elevated in symptomatic compared with asymptomatic plaques and is associated with acute ischemic syndromes, possibly through the generation of LTB4, subsequent MMP biosynthesis, and plaque rupture.
Journal ArticleDOI

Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes

TL;DR: This study supports the hypothesis that simvastatin inhibits plaque RAGE expression by decreasing MPO-dependent AGE generation, which might contribute to plaque stabilization by inhibiting the biosynthesis of PGE2-dependent MMPs, responsible for plaque rupture.
Journal ArticleDOI

A Unique MicroRNA Signature Associated With Plaque Instability in Humans

TL;DR: It is suggested that miRNAs may have an important role in regulating the evolution of atherosclerotic plaque toward instability and rupture and by identifying the specific miRNA signature for stroke now, the authors are able to use computer algorithms to identify previously unrecognized molecular targets.
Journal ArticleDOI

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.

TL;DR: This study demonstrates that simvastatin decreases inflammation and inhibits COX-2/mPGES expression in plaque macrophages, and this effect in turn may contribute to plaque stabilization by inhibition of MMP-induced plaque rupture.